NEW YORK, Oct. 12, 2015 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM) is pleased to congratulate Titan Pharmaceuticals, Inc., a South San Francisco-based specialty pharmaceutical company, on its graduation to the NASDAQ Capital Market. The company previously traded on the OTCQB® Venture Market operated by OTC Markets Group.
Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO
In the past 12 months on OTCQB, Titan Pharmaceuticals' share price has increased nearly 50%. The company has a market capitalization of $80.4 million.
"We commend Titan Pharmaceuticals on its NASDAQ listing and are proud to have contributed to its achievement of this important milestone," said Jason Paltrowitz, Executive Vice President - Corporate Services of OTC Markets Group. "Our OTCQX Best and OTCQB Venture Markets provide efficient, transparent public trading markets for developing companies like Titan Pharmaceuticals that are looking to raise capital, attract new shareholders and grow their businesses for the future."
Titan Pharmaceuticals is the 48th company to graduate to a U.S. stock exchange this year. Other 2015 graduates include: AmpliPhi Biosciences Corp., CRH Medical Corp. and Klondex Mines Ltd.
OTC Markets Group is a global leader in exchange graduates, advancing more than 400 companies to the New York Stock Exchange, NASDAQ and NYSE MKT in the past nine years.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial markets for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into markets to inform investors of opportunities and risks: the OTCQX® Best Market; the OTCQB® Venture Market; and the OTC Pink® Open Market. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial markets, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
Media Contact:
Saskia Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428, [email protected]
SOURCE OTC Markets Group Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article